AR047581A1 - Vacunas de calicivirus felino - Google Patents

Vacunas de calicivirus felino

Info

Publication number
AR047581A1
AR047581A1 ARP050100207A ARP050100207A AR047581A1 AR 047581 A1 AR047581 A1 AR 047581A1 AR P050100207 A ARP050100207 A AR P050100207A AR P050100207 A ARP050100207 A AR P050100207A AR 047581 A1 AR047581 A1 AR 047581A1
Authority
AR
Argentina
Prior art keywords
vaccine
feline calicivirus
nucleic acid
isolated
capsid protein
Prior art date
Application number
ARP050100207A
Other languages
English (en)
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of AR047581A1 publication Critical patent/AR047581A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/16011—Caliciviridae
    • C12N2770/16034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/16011—Caliciviridae
    • C12N2770/16041—Use of virus, viral particle or viral elements as a vector
    • C12N2770/16043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/16011—Caliciviridae
    • C12N2770/16061—Methods of inactivation or attenuation

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Microbiology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

Vacuna para inmunizar a un gato frente al calicivirus felino. Clon de ácido nucleico que codifica la proteína de la cápsida del calicivirus felino aislado. Vacuna viva o muerta que comprende el calicivirus felino aislado, una vacuna de subunidad que comprende la proteína de la cápsida del calicivirus felino aislado, una vacuna de ácido nucleico que comprende un clon de ácido nucleico de calicivirus felino aislado, y una vacuna de vector de virus recombinante que comprende un ácido nucleico que codifica la proteína de la cápsida del calicivirus felino aislado. Método para identificar un calicivirus util para producir una composicion de vacuna y para ensayos para diagnosticar a gatos infectados por el calicivirus felino. Método de tratamiento.
ARP050100207A 2004-01-20 2005-01-20 Vacunas de calicivirus felino AR047581A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US53768304P 2004-01-20 2004-01-20

Publications (1)

Publication Number Publication Date
AR047581A1 true AR047581A1 (es) 2006-01-25

Family

ID=34885937

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP050100207A AR047581A1 (es) 2004-01-20 2005-01-20 Vacunas de calicivirus felino

Country Status (3)

Country Link
AR (1) AR047581A1 (es)
TW (1) TW200538153A (es)
WO (1) WO2005080416A1 (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7850978B2 (en) * 1999-07-16 2010-12-14 Merial Limited Vaccine against feline calicivirus
CN101563096A (zh) 2005-07-28 2009-10-21 辉瑞产品公司 疫苗施用方法、新猫杯状病毒、及抗猫细小病毒和猫疱疹病毒的动物免疫方法
NZ740551A (en) * 2015-08-20 2019-10-25 Boehringer Ingelheim Animal Health Usa Inc Fcv recombinant vaccines and uses thereof
WO2017106079A1 (en) 2015-12-14 2017-06-22 Boehringer Ingelheim Vetmedica, Inc. Hybrid core feline vaccines
US10421790B2 (en) 2015-12-23 2019-09-24 Intervet, Inc. Feline calicivirus vaccine
CN110272488B (zh) * 2018-03-16 2022-05-17 洛阳普泰生物技术有限公司 猫杯状病毒单克隆抗体及其应用
CN112877297A (zh) * 2021-03-27 2021-06-01 哈尔滨元亨生物药业有限公司 一种利用生物反应器制备猫瘟热病毒单克隆抗体的方法
CN113801243B (zh) * 2021-09-27 2022-08-09 中国农业科学院上海兽医研究所(中国动物卫生与流行病学中心上海分中心) 猫杯状病毒gi和gii株群通用抗原表位的串联表达及其间接elisa方法的建立
CN114874997B (zh) * 2022-05-26 2023-05-23 中国农业科学院哈尔滨兽医研究所（中国动物卫生与流行病学中心哈尔滨分中心） 猫杯状病毒

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0484382B1 (en) * 1989-07-21 1995-03-08 The Upjohn Company Feline calicivirus capsid protein and nucleotide sequence
AU5329300A (en) * 1999-06-10 2001-01-02 Michigan State University Feline calicivirus isolated from cat urine and vaccines thereof

Also Published As

Publication number Publication date
TW200538153A (en) 2005-12-01
WO2005080416A1 (en) 2005-09-01

Similar Documents

Publication Publication Date Title
AR047581A1 (es) Vacunas de calicivirus felino
ATE461710T1 (de) Nipah-virus-impfstoffe
MXPA05009580A (es) Vacuna contra el virus de la influenza.
NO20080046L (no) Fremgangsmater for administrering av vaksine, nye feline calicivirus, og behandlinger for a immunisere dyr mot feline paraovirus og feline herpesvirus
BRPI0923599A2 (pt) vírus da febre suína clássica recombinante, vacina para febre suína clássica viva, métodos para proteger um animal contra a febre suína clássica, para diferenciar animais infectados com o vírus da febre suína clássica de animais não infectados ou de animais vacinados com a vacina para febre suína clássica, e para isolar um vírus da febre suína clássica recombinante infeccioso, molécula de cdna, uso do vírus da febre suína clássica recombinante infeccioso, e, elisa com base em peptídeo
RU2008107875A (ru) Модифицированный вирус гриппа, предназначенный для мониторинга и повышения эффективности вакцины
CY1113540T1 (el) Εμβολια γριππης σκυλων
NZ735684A (en) Materials and methods for respiratory disease control in canines
IL213189A (en) A vaccine containing avian influenza antigen, a method for vaccinating animals with the vaccine, antigen-encoded DNA and its uses
EA201001045A1 (ru) Модифицированный вирус гриппа
CY1111521T1 (el) Λοιμογονος συστηματικος καλυκοϊος αιλουροειδων
AR094725A1 (es) Parvovirus 5a porcino, métodos de uso y vacuna
CY1112575T1 (el) Βελτιωμενα αδρανοποιημενα εμβολια fcv
EP2528931A4 (en) CYCLOVIRUS AND USE METHOD THEREFOR
CL2008003845A1 (es) Vacuna que comprende una emulsion, una bacterina tratada termicamente a 55-70°c por 5-10 horas, que comprende una suspension de bacterias muertas de la especie leptospira bratislava, y de 1 a 13 virus causantes de enfermedad porcina.
EA201500837A1 (ru) Парвовирус свиней 5в, способы применения и вакцина
ATE507286T1 (de) Immunisierung von fischen gegen virusinfektion
MX2021012695A (es) Vacuna de subunidad del virus de la fiebre porcina clasica (csfv).
AR067439A1 (es) Virus quimericos antigenicos de virus de encefalitis de st. louis/virus dengue tipo 4
BRPI0822947A2 (pt) Vacina recombinante, método para vacinação contra doenças de animais e método para identificação entre animais infectados e animais vacinados
EA200401505A1 (ru) Экспрессия генов модифицированного вируса осповакцины ankara с использованием ati-промотора вируса коровьей оспы
BR112012004847A2 (pt) genoma bohv-4 mutante, vírus bohv-4 mutante, vacina, uso de um vírus bohv-4 mutante, célula, método para a produção de um genoma bohv-4 mutante ou um vírus bohv-4 mutante, e, kit de teste de diagnóstico para diferenciar animais infectados.
TW200710224A (en) Attenuated avian infectious bronchitis virus vaccines
DE602004019971D1 (de) Kombinationsvakzine für geflügel
DE60236943D1 (de) Induzierte immunantwort gegen den katzen-immunschwäche-virus

Legal Events

Date Code Title Description
FB Suspension of granting procedure